IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...
A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for ...
("Owlet" or the "Company") (NYSE: OWLT), the pioneer of smart infant monitoring, announced today that it will participate in TD Cowen's 45th Annual Health Care Conference on March 5, 2025 at the ...
Biodesix is a leading diagnostic solutions company with five Medicare-covered tests available for pulmonology patients. The ...
About Septerna Septerna, Inc. is a biotechnology company pioneering a new era of GPCR drug discovery powered by its proprietary Native Complex Platformâ„¢. Its industrial-scale platform aims to unlock ...
About Avalyn Pharma. Avalyn is a biopharmaceutical company developing inhaled therapies for the treatment of rare respiratory ...
announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time. Interested investors and ...
today announced that it will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference to take place on March 3-5, 2025.
will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 3:10 p.m. ET in Boston, MA. A live webcast of the presentation will be available on the Nuvation Bio ...
will participate in 1x1 meetings at the TD Cowen 45th Annual Health Care Conference on Wednesday March 5 th, and will deliver a presentation at 11:10 – 11:40 AM ET on that day. A webcast of the ...
today announced that the company will present at the TD Cowen 45 th Annual Health Care Conference on Wednesday, March 5, 2025, from 9:50 a.m. – 10:20 a.m. ET. Zhenya Lindgardt, President and CEO, will ...